Reducing time delays in the administration of thrombolytic therapy to patients with acute myocardial infarction

Daniel E. Hilleman, J. M. Gannon

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

The extent of myocardial damage occurring during acute myocardial infarction is time dependent. Current approaches designed to reduce the time between symptom onset and the initiation of thrombolytic therapy have focused on increasing public awareness of the need to seek prompt medical attention, prehospital administration of thrombolytic agents, and reducing inhospital delays in initiation of therapy. Results from short-term, public awareness campaigns suggest that patient delays in seeking medical assistance can be reduced in some communities; however, these campaigns do not influence overall patient use of emergency rooms and emergency transport services. In addition, the long-term benefit of media campaigns has not been demonstrated. Prehospital thombolytic therapy appears to be feasible and safe in certain communities, but definite therapeutic benefit of the small time savings realized in studies to date has not been seen. Even if prehospital thrombolysis is proven to benefit selected patients, it will not affect the large number of patients who choose not to use emergency medical transport services. Adherence to established protocols designed to facilitate rapid institution of thrombolytic therapy can reduce inhospital delays. Initiating thrombolytic therapy within 30 minutes of patient arrival in the emergency department is a goal that should be readily achievable in today's health care environment.

Original languageEnglish
Pages (from-to)1096-1100
Number of pages5
JournalDICP, Annals of Pharmacotherapy
Volume25
Issue number10
StatePublished - 1991

Fingerprint

Thrombolytic Therapy
Myocardial Infarction
Hospital Emergency Service
Medical Assistance
Therapeutic Community
Fibrinolytic Agents
Emergency Medical Services
Emergencies
Delivery of Health Care
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Reducing time delays in the administration of thrombolytic therapy to patients with acute myocardial infarction. / Hilleman, Daniel E.; Gannon, J. M.

In: DICP, Annals of Pharmacotherapy, Vol. 25, No. 10, 1991, p. 1096-1100.

Research output: Contribution to journalReview article

@article{fe00dcaeb436441fa951580063bac1af,
title = "Reducing time delays in the administration of thrombolytic therapy to patients with acute myocardial infarction",
abstract = "The extent of myocardial damage occurring during acute myocardial infarction is time dependent. Current approaches designed to reduce the time between symptom onset and the initiation of thrombolytic therapy have focused on increasing public awareness of the need to seek prompt medical attention, prehospital administration of thrombolytic agents, and reducing inhospital delays in initiation of therapy. Results from short-term, public awareness campaigns suggest that patient delays in seeking medical assistance can be reduced in some communities; however, these campaigns do not influence overall patient use of emergency rooms and emergency transport services. In addition, the long-term benefit of media campaigns has not been demonstrated. Prehospital thombolytic therapy appears to be feasible and safe in certain communities, but definite therapeutic benefit of the small time savings realized in studies to date has not been seen. Even if prehospital thrombolysis is proven to benefit selected patients, it will not affect the large number of patients who choose not to use emergency medical transport services. Adherence to established protocols designed to facilitate rapid institution of thrombolytic therapy can reduce inhospital delays. Initiating thrombolytic therapy within 30 minutes of patient arrival in the emergency department is a goal that should be readily achievable in today's health care environment.",
author = "Hilleman, {Daniel E.} and Gannon, {J. M.}",
year = "1991",
language = "English",
volume = "25",
pages = "1096--1100",
journal = "Annals of Pharmacotherapy",
issn = "1060-0280",
publisher = "Harvey Whitney Books Company",
number = "10",

}

TY - JOUR

T1 - Reducing time delays in the administration of thrombolytic therapy to patients with acute myocardial infarction

AU - Hilleman, Daniel E.

AU - Gannon, J. M.

PY - 1991

Y1 - 1991

N2 - The extent of myocardial damage occurring during acute myocardial infarction is time dependent. Current approaches designed to reduce the time between symptom onset and the initiation of thrombolytic therapy have focused on increasing public awareness of the need to seek prompt medical attention, prehospital administration of thrombolytic agents, and reducing inhospital delays in initiation of therapy. Results from short-term, public awareness campaigns suggest that patient delays in seeking medical assistance can be reduced in some communities; however, these campaigns do not influence overall patient use of emergency rooms and emergency transport services. In addition, the long-term benefit of media campaigns has not been demonstrated. Prehospital thombolytic therapy appears to be feasible and safe in certain communities, but definite therapeutic benefit of the small time savings realized in studies to date has not been seen. Even if prehospital thrombolysis is proven to benefit selected patients, it will not affect the large number of patients who choose not to use emergency medical transport services. Adherence to established protocols designed to facilitate rapid institution of thrombolytic therapy can reduce inhospital delays. Initiating thrombolytic therapy within 30 minutes of patient arrival in the emergency department is a goal that should be readily achievable in today's health care environment.

AB - The extent of myocardial damage occurring during acute myocardial infarction is time dependent. Current approaches designed to reduce the time between symptom onset and the initiation of thrombolytic therapy have focused on increasing public awareness of the need to seek prompt medical attention, prehospital administration of thrombolytic agents, and reducing inhospital delays in initiation of therapy. Results from short-term, public awareness campaigns suggest that patient delays in seeking medical assistance can be reduced in some communities; however, these campaigns do not influence overall patient use of emergency rooms and emergency transport services. In addition, the long-term benefit of media campaigns has not been demonstrated. Prehospital thombolytic therapy appears to be feasible and safe in certain communities, but definite therapeutic benefit of the small time savings realized in studies to date has not been seen. Even if prehospital thrombolysis is proven to benefit selected patients, it will not affect the large number of patients who choose not to use emergency medical transport services. Adherence to established protocols designed to facilitate rapid institution of thrombolytic therapy can reduce inhospital delays. Initiating thrombolytic therapy within 30 minutes of patient arrival in the emergency department is a goal that should be readily achievable in today's health care environment.

UR - http://www.scopus.com/inward/record.url?scp=0026047162&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026047162&partnerID=8YFLogxK

M3 - Review article

C2 - 1803800

AN - SCOPUS:0026047162

VL - 25

SP - 1096

EP - 1100

JO - Annals of Pharmacotherapy

JF - Annals of Pharmacotherapy

SN - 1060-0280

IS - 10

ER -